匿名化醫療保健數據市場：按數據類型、應用、最終用戶和地區分類

De-Identified Health Data Market, By Type of Data, By Application, By End User, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，匿名化醫療保健數據市場規模估計為90億美元，預計2033年將達到169.7億美元。預計從2026年到2033年，該市場將以9.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	90億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.50%	2033年市場規模預測：	169.7億美元

匿名化醫療數據市場的成長主要受藥物研發和精準醫療領域研發活動的推動。匿名化透過從醫療資料集中移除姓名、出生日期和社會安全號碼等識別訊息，確保病患隱私和保密性。這使得研究人員和生命科學公司能夠在不違反倫理的前提下，利用大量醫療數據開發新治療方法和進行流行病學研究。隨著全球醫療記錄數位化進程的加速，可供二次利用的去識別化資料量也將隨之增加。

市場動態

對以價值為導向的醫療保健、個人化治療以及數位醫療新創公司的日益重視，可能會推動全球對匿名化醫療保健數據的需求。然而，資料標準化的缺失和知識產權方面的模糊性可能會阻礙市場潛力。開發先進的分析能力將使每個參與者有機會從整合的數據資產中挖掘更深層的見解。擴大政府開放資料共用計畫可以拓寬對這些資料集的存取。美國政府推出Data.gov和HealthData.gov等舉措，旨在提供對各種健康相關資料集的開放訪問，從而促進公共衛生研究的透明度和創新。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球匿名醫療保健數據市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球去識別化醫療數據市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球匿名醫療數據市場中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

IQVIA
Oracle（Cerner Corporation）
Merative（Truven Health Analytics）
Optum, Inc.
BioTelemetry, Inc.
Flatiron Health
Veradigm LLC
Medidata Solutions
Evidation Health, Inc.
Komodo Health, Inc.
Sundown Solutions, LLC
Clarify Health Solutions
Akrivia Health
Satori Cyber Ltd.
Tempus
nference
Ciox Health
HealthVerity
Zebra Medical Vision
Huma Therapeutics

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI7476

De-Identified Health Data Market is estimated to be valued at USD 9 Bn in 2026 and is expected to reach USD 16.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.50%	2033 Value Projection:	USD 16.97 Bn

De identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de identified data available for secondary usage.

Market Dynamics

Rising focus on value based care, personalization of treatment, and growth of digital health startups can boost demand for de identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health related datasets to encourage transparency and innovation in public health research.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global de identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
Global de identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global de identified health data market.

Market Segmentation

Type of Data Insights (Revenue, USD Bn, 2021 - 2033)
Clinical Data
Genomic Data
Patient Demographics
Prescription Data
Claims Data
Behavioral Data
Wearable and Sensor Data
Survey and Patient-Reported Data
Imaging Data
Laboratory Data
Social Determinants of Health (SDOH) Data
Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Clinical Research and Trials
Public Health
Precision Medicine
Health Economics and Outcomes Research (HEOR)
Population Health Management
Drug Discovery and Development
Healthcare Quality Improvement
Insurance Underwriting and Risk Assessment
Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
Pharmaceutical Companies
Biotechnology Firms
Healthcare Providers
Insurance Companies/Healthcare Payers
Research Institutions
Government Agencies
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
IQVIA
Oracle (Cerner Corporation)
Merative (Truven Health Analytics)
Optum, Inc.
BioTelemetry, Inc.
Flatiron Health
Veradigm LLC
Medidata Solutions
Evidation Health, Inc.
Komodo Health, Inc.
Sundown Solutions, LLC
Clarify Health Solutions
Akrivia Health
Satori Cyber Ltd.
Tempus
nference
Ciox Health
HealthVerity
Zebra Medical Vision
Huma Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- De-identified Health Data Market, By Type of Data
- De-identified Health Data Market, By Application
- De-identified Health Data Market, By End User
- De-identified Health Data Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. De-identified Health Data Market, By Type of Data, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Clinical Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Genomic Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Patient Demographics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Prescription Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Claims Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Behavioral Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Wearable and Sensor Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Survey and Patient-Reported Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Imaging Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Laboratory Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Social Determinants of Health (SDOH) Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. De-identified Health Data Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Clinical Research and Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Public Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Health Economics and Outcomes Research (HEOR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Population Health Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Healthcare Quality Improvement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Insurance Underwriting and Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. De-identified Health Data Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Biotechnology Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Insurance Companies/Healthcare Payers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Government Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. De-identified Health Data Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive landscape

IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oracle (Cerner Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merative (Truven Health Analytics)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Optum, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioTelemetry, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Veradigm LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medidata Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evidation Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Komodo Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sundown Solutions, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Clarify Health Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Akrivia Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Satori Cyber Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Tempus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
nference
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ciox Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
HealthVerity
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zebra Medical Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Huma Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies